A Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines
Clinical trial NCT06583486 · COMPLETED
Trial details
- NCT number
- NCT06583486
- Sponsor
- Chongqing Claruvis Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-19
- Primary completion
- 2025-08-25
- Enrollment
- 488
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.